Evidence map›Paper›PMID 33334912›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

SNMMI Procedure Standard/EANM Practice Guideline on Pediatric

Reza Vali, Adam Alessio, Rene Balza, Lise Borgwardt, Zvi Bar-Sever, Michael Czachowski, Nina Jehanno, Lars Kurch, Neeta Pandit-Taskar, Marguerite Parisi and 5 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06612567 (Normal Variants and Pitfalls of 18F_FDG PET/CT Imaging in Pediatric Oncology), which is not on this map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06612567 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Normal Variants and Pitfalls of 18F_FDG PET/CT Imaging in Pediatric Oncology

TypeobservationalSponsorAssiut UniversityRan2024 to 2026Enrolled120ConditionsPitfalls of PET Scan on PediatticArmsPET/CT
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. How can children benefit from total-body PET?The British journal of radiology · 2026
    Review
  3. Whole-Body MRI VersusCancers · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. [American journal of nuclear medicine and molecular imaging · 2026
    Review
  10. Nuclear medicine and molecular imaging · 2025
    Article
  11. Article
  12. Assessment of reducedAnnals of nuclear medicine · 2025
    Article
  13. The baselineBMC medical imaging · 2025
    Article
  14. Total-bodyEJNMMI research · 2025
    Article
  15. Imaging insights of FDG-PET from neonates to infants.Japanese journal of radiology · 2025
    Review
  16. Article
  17. Review
  18. A low-dose protocol in pediatricAnnals of nuclear medicine · 2025
    Article
  19. Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  20. Nuclear medicine and molecular imaging · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 14 institutions in 7 countries.

Reza ValiDepartment of Diagnostic Imaging, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Adam AlessioMichigan State University, East Lansing, Michigan.
Rene BalzaDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Lise BorgwardtDepartment for Clinical Physiology, Nuclear Medicine & PET, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Zvi Bar-SeverSchneider Children's Medical Center, Petach Tikva, Israel.
Michael CzachowskiUPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Nina JehannoDepartment of Nuclear Medicine, Institut Curie, Paris, France.
Lars KurchUniversity Hospital Leipzig, Department of Nuclear Medicine, Leipzig, Germany.
Neeta Pandit-TaskarMemorial Sloan Kettering Cancer Center, New York, New York.
Marguerite ParisiUniversity of Washington School of Medicine and Seattle Children's Hospital, Seattle, Washington.
Arnoldo PiccardoEnte Ospedaliero "Ospedali Galliera," Genoa, Italy.
Victor SeghersTexas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Barry L ShulkinSt. Jude Children's Research Hospital, Memphis, Tennessee; and.
Pietro ZucchettaUniversity Hospital, Padova, Italy.
Ruth LimDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts ruthlimmd@yahoo.com.
Harvard University · USBaylor College of Medicine · USChildren's Hospital of Pittsburgh · USEnte Ospedaliero Ospedali Galliera · ITInstitut Curie · FRMemorial Sloan Kettering Cancer Center · USMichigan State University · USRigshospitalet · DKSchneider Children's Medical Center · ILSickKids Foundation · CASt. Jude Children's Research Hospital · USUniversity Hospital Leipzig · DEUniversity of Padua · ITUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PREAMBLEThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association founded in 1985 to facilitate communication worldwide among individuals pursuing clinical and academic excellence in nuclear medicine. SNMMI and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine.The SNMMI and EANM will periodically put forth new standards/guidelines for nuclear medicine practice to help advance the science of nuclear medicine and improve service to patients. Existing standards/guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each standard/guideline, representing a policy statement by the SNMMI/EANM, has undergone a thorough consensus process, entailing extensive review. The SNMMI and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging requires particular training and skills, as described in each document. These standards/guidelines are educational tools designed to assist practitioners in providing appropriate and effective nuclear medicine care for patients. These guidelines are consensus documents, and are not inflexible rules or requirements of practice. They are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the SNMMI and the EANM cautions against the use of these standards/guidelines in litigation in which the clinical decisions of a practitioner are called into question.The ultimate judgment regarding the propriety of any specific procedure or course of action must be made by medical professionals taking into account the unique circumstances of each case. Thus, there is no implication that action differing from what is laid out in the standards/guidelines, standing alone, is below standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set forth in the standards/guidelines when, in the reasonable judgment of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology subsequent to publication of the standards/guidelines.The practice of medicine involves not only the science, but also the art of dealing with the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible for general guidelines to consistently allow for an accurate diagnosis to be reached or a particular treatment response to be predicted. Therefore, it should be recognized that adherence to these standards/guidelines will not ensure a successful outcome. All that should be expected is that the practitioner follows a reasonable course of action, based on their level of training, the current knowledge, the available resources, and the needs/context of the particular patient being treated.PET and computerized tomography (CT) have been widely used in oncology.

Indexed as

Fluorodeoxyglucose F18Nuclear MedicinePositron Emission Tomography Computed TomographyPractice Guidelines as TopicSocieties, MedicalDocumentationEuropeHumansImage Processing, Computer-AssistedRadiopharmaceuticalsReference StandardsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID33334912
PMCPMC8679588
OpenAlexW3111790894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.